Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

Trial ID or NCT#

NCT03020472

Status

not recruiting iconNOT RECRUITING

Purpose

This pilot study will investigate B-cell responses following vaccination with live, attenuated influenza vaccine (LAIV) in healthy children 2 years of age from blood samples taken at designated time points before and after vaccination.

Official Title

U19 Year 6: Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age, SLVP016

Eligibility Criteria

Ages Eligible for Study: 24 Months to 35 Months
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Show Less

Investigator(s)

Harry B Greenberg
Cornelia L. Dekker, M.D.

View on ClinicalTrials.gov